tradingkey.logo

Macrogenics Announces Pausing Of Enrollment Of New Study Participants In Linnet Trial

ReutersFeb 23, 2026 11:31 PM

- MacroGenics Inc MGNX.O:

  • MACROGENICS ANNOUNCES PAUSING OF ENROLLMENT OF NEW STUDY PARTICIPANTS IN LINNET TRIAL

  • MACROGENICS INC: U. S. FOOD AND DRUG ADMINISTRATION (FDA) HAS PLACED A PARTIAL CLINICAL HOLD ON ITS PHASE 2 LINNET STUDY OF LORIGERLIMAB

  • MACROGENICS INC: CURRENT STUDY PARTICIPANTS MAY CONTINUE TO RECEIVE STUDY DRUG

  • MACROGENICS: FDA'S PARTIAL CLINICAL HOLD INITIATED AFTER CO'S NOTIFICATION TO FDA OF TEMPORARY PAUSE IN ENROLLMENT OF NEW PARTICIPANTS IN LINNET TRIAL

  • MACROGENICS: TEMPORARY PAUSE IN ENROLLMENT OF NEW PARTICIPANTS IN LINNET TRIAL DUE TO OCCURRENCE OF RECENT SAFETY EVENTS

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI